Selected References
Screening for Diabetes Mellitus in the Non-Pregnant Adult
Adapted by Marie-Dominique Beaulieu, MD, MSc,
FCFP, Associate Professor, University of Montreal, Quebec, from materials
prepared for the U.S. Preventive Services Task Force
These recommendations were finalized by the Task Force in January 1994
1. Report of a Task Force to the Conference of Deputy Ministers
of Health (cat no H39-3/1980E), Health Services and Promotion Branch,
Deptartment of National Health and Welfare, Ottawa, 1980
2. The Canada Health Survey 1976: Department of Health and Welfare
and Statistics Canada, Ottawa, 1978
3. Young TK, Roos NP, Hammerstrand KM: Estimated burden of diabetes mellitus
in Manitoba according to health insurance claims: a pilot study. Can
Med Assoc J 1991; 144: 318-324
4. Brassard P, Robinson E, Lavallée C: Prevalence of diabetes mellitus
among the James Bay Cree of northern Quebec. Can Med Assoc J 1993;
149: 303-307
5. Harati Y: Diabetic peripheral neuropathies. Ann Int Med 1987;
107: 546-559
6. Zinmam B: Preventing the complications of diabetes mellitus. Can
J Diagnosis, June 1993: 149-159
7. Expert Committee of the Canadian Diabetes Advisory Board: Clinical practice
guidelines for the treatment of diabetes mellitus. Can Med Assoc J
1992; 147: 697-712
8. Eisenbarth GS, Verge CF, Allen H, et al: The design of trials
for prevention of IDDM. Diabetes 1993; 42: 941-947
9. National Diabetes Data Group: Classification and diagnosis of diabetes
mellitus and other categories of glucose intolerance. Diabetes 1979;
28: 1039-1057
10. Bourn D, Mann J: Screening for noninsulin dependent diabetes mellitus
and impaired glucose tolerance in a Dunedin general practice - is it worth
it? N Z Med J 1992; 105: 208-210
11. Croxson SC, Absalom S, Burden AC: Fructosamine in diabetes screening
of the elderly. Ann Clin Biochem 1991; 28: 279-282
12. Guillausseau PJ, Charles MA, Paolaggi F, et al: Comparison of
HbA1 and fructosamine in diagnosis of glucose-tolerance abnormalities.
Diabetes
Care 1990; 13: 898-900
13. Little RR, England JD, Wiedmeyer HM, et al: Relationship of
glycosylated hemoglobin to oral glucose tolerance. Diabetes 1988;
37: 60-64
14. Singer DE, Coley CM, Samet JH, et al: Tests of glycemia in diabetes
mellitus. Their use in establishing a diagnosis and treatment. Ann Int
Med 1989; 110: 125-137
15. Welborn TA, Wearne K: Coronary Heart disease incidence and cardiovascular
mortality in Busselton with reference to glucose and insulin concentrations.
Diabetes
Care 1979; 2: 154-160
16. Motala AA, Omar MA, Gouws E: High risk of progression to NIDDM in South-African
Indians with impaired glucose tolerance. Diabetes 1993; 42: 556-563
17. Harris MI: Undiagnosed NIDDM: clinical and public health issues. Diabetes
Care 1993; 16: 642-652
18. Jarrett RJ, Keen H, McCartney P: The Whitehall study: ten year follow-up
report on men with impaired glucose tolerance with reference to worsening
of diabetes and predictors of death. Diabet Med 1984; 1: 279-283
19. U.S. Preventive Services Task Force: Guide to Clinical Preventive
Services: an Assessment of the Effectiveness of 169 Interventions.
Williams & Wilkins, Baltimore, Md, 1989: 95-103
Link to Full Text of this
review
Link to Structured Abstract of
this review
Link to Summary Table of Recommendations of this review
Top of Page
CTFPHC
Home Page
Reprinted in modified format by the Canadian
Task Force on Preventive Health Care
with permission.
Original Copyright
© 1994 Minister of Supply and Services Canada.
For any technical issues please contact: webmaster@ctfphc.org
Last modified March 27, 1998.